虎杖内生真菌产白藜芦醇苷菌株的分离鉴定

利用组织培养法对秦巴山区虎杖进行内生真菌分离,通过内生真菌的液体发酵,对发酵液和菌丝的乙酸乙酯萃取液进行HPLC分析检测,筛选出一株产白藜芦醇苷的菌株M-56,其产量达1.029 mg/L。根据该菌株的形态特征及菌丝ITS序列分析,将该株菌确定为无性型真菌丝孢纲链格孢菌Alternaria alternaria。     

喜树内生真菌的分离、鉴定以及抗植物病原菌活性的初步研究

对喜树植株中的内生真菌进行分离纯化,共得到126株内生菌株。对126株内生菌株进行液体培养,并对其发酵产物进行抗菌活性测定。发现在供试质量浓度为5mg／mL时,126株菌株中有24株喜树内生真菌的发酵液对水稻纹枯病菌、稻瘟病菌以及辣椒疫霉具有不同程度的抑制菌丝生长的活性作用;其中,菌株XSY09的发酵液对此三种植物病原菌有明显的抑制作用,抑制率分别为74．97％、39．63％和58．49％。在0．1mg／mL的测试浓度下,菌株XSY09发酵液的乙酸乙酯相对三种植物病原菌均有较好的抑制作用。对该菌株的ITS序列进行测序分析,初步鉴定XSY09为炭疽菌属（Colletotrichum gloeosporioides）真菌。     

陕北野生甘草内生菌的分离及抑菌活性筛选

采用组织块分离法从陕北野生甘草根中分离出21株内生菌,其中细菌12株,真菌6株,放线菌3株.为明确内生菌代谢产物的抑菌活性,采用抑制菌丝生长速率法和组织测定法系统测定了其发酵液对植物病原真菌的抑制作用.结果表明,在离体条件下,甘草内生菌发酵液对供试的7种植物病原菌菌丝生长均有一定的抑制作用,其中Z4和F1菌株的发酵液对供试病原菌菌丝生长的抑制作用较强,特别是对苹果干腐病菌和烟草赤星病菌的抑制作用最强,抑制率分别可达92.36%、90.16%和91.20%、90.43%,EC50分别仅为54.38、90.31和57.50、89.58 mg·L-1;组织法测定中,发酵液稀释10倍后,Z4和F1菌株对苹果干腐病的保护作用分别为75.39%和73.13%,治疗效果分别为67.61%和60.75%.     

除虫菊内生真菌的分离及其发酵产物抑菌活性筛选

从除虫菊(Pyrethrumcinerariifolium Trev.)的根、茎、叶和花中分离出128株内生真菌。生长速率法测定结果表明,有56株内生真菌发酵液10倍稀释液至少对供试的番茄灰霉病菌(Botrytis cinerea)、辣椒疫霉病菌(Phytophthora capsici)、苹果炭疽病菌(Colletotrichum gloeosporioides)、玉米大斑病菌(Exserohilumturcicum)、小麦纹枯病菌(Rhizoctonia cerealis)和小麦赤霉病菌(Fusarium graminearum)等6种病原菌中的一种抑菌活性达75%以上;活体组织法测定结果,Y1、Y2、H2共3株菌的发酵液对番茄灰霉病的防效达到50%以上;盆栽试验结果表明,Y1、Y2、Y7、H2、G13共5株菌株发酵液对辣椒疫霉病的防治效果达到50%以上。综合分析认为,Y1、Y2、H2、G13等内生真菌的抑菌作用值得进一步研究。     

连翘内生真菌的分离鉴定及其发酵液抑菌活性和HPLC测定

为获得能产生抑菌活性物质的连翘内生菌,从连翘新鲜组织中分离纯化内生真菌并进行形态学分析,牛津杯法测定发酵液的抑菌活性,对具有抑菌活性的菌株进行18S rRNA基因序列分析,并以连翘主要活性成分连翘苷和连翘酯苷A、B标准品为对照,HPLC测定发酵上清液中的连翘苷和连翘酯苷A、B含量。结果表明从连翘新鲜组织中获得了5株内生真菌,其中4株菌的发酵上清液对金黄色葡萄球菌和肠炎沙门氏菌有很好的抑菌活性,对这4株菌的分子生物学检测表明3株菌为枝胞菌,另1株菌为曲霉菌,HPLC结果显示这4株菌的发酵上清液中均含有一定浓度的连翘苷和连翘酯苷A、B,发酵液中发挥抑菌活性的成分是否与这三种物质有关需要进一步研究,但连翘内生真菌可以产生抑菌活性物质这一结果为后续利用微生物发酵生产抑菌物质提供了新的途径和新的菌种来源。     

一株具有抗疟活性的金鸡纳树内生真菌的研究

为筛选具抗疟疾活性的的内生真菌,采用平板分离法对海南金鸡那树内生真菌进行分离纯化。利用"4日抑制疟疾"测试内生真菌发酵液的抗疟活性,采用TLC、HPLC等分析技术对内生菌发酵液等成分进行分析。从金鸡那树叶片分离到31种内生真菌,通过筛选找到了1株具有抗疟疾活性的产奎宁或奎宁类似物的内生真菌。从金鸡那树叶片中分离得到1株产奎宁的结实串孢霉属内生真菌,为奎宁的资源开发开辟了新途径。     

大花金挖耳内生菌的分离及抑菌活性筛选

从菊科植物大花金挖耳（Carpesium macrocephalum）的花、茎、叶、果实和根中分离出92株内生菌,其中真菌68株,细菌16株,放线菌8株;对峙法生物活性测定结果表明,其中22株内生菌分别对小麦赤霉病菌、黄瓜灰霉病菌、辣椒疫霉病菌、玉米大斑病菌和苹果炭疽病菌均有较好的拮抗作用;采用生长速率法测定22株内生菌发酵产物的抑菌活性,结果表明,内生细菌H-32的发酵液稀释10倍和内生真菌H-18、Y-12、G-4、G-6的菌丝丙酮提取物在0.5 mg·mL^-1（菌丝干重）的剂量下,均对番茄灰霉病菌和玉米大斑病菌菌丝生长具75%以上的抑制效果;活体组织法测定结果,H-32的发酵液和H-18、J-1、Y-17、G-6的菌丝丙酮提取物在2.0 mg·mL^-1（菌丝干重）的剂量下,对番茄灰霉病的防治效果均在50%以上.综合分析认为,H-32、H-18和G-6等内生菌的抑菌作用值得进一步研究.     

苦楝内生真菌抗植物病原真菌活性菌株的筛选

实验对苦楝植株中内生真菌的抗植物病原真菌活性进行了研究。从苦楝（Melia azedarach）的根、茎、叶、花、果实中分离得到290株内生真菌,分别测定各菌株的抗菌活性效果,并对筛选出的9株菌株发酵液进行抗菌活性测定。发现L071027Z3、SX071116Z1-2和XY070430J3菌株发酵液对玉米小斑病,小麦赤霉病,棉花枯萎病,苹果炭疽病的抑制率较高。再对这3株供试菌在发酵液粗提物质量浓度为50 mg/mL时,进行进一步抑菌实验,3个菌株的发酵液粗提物对玉米小斑病,小麦赤霉病,棉花枯萎病,苹果炭疽病具有不同程度的抑制菌丝生长活性作用且有机相提取物的抑制作用较高,其中L071027Z3的抑菌圈与其它菌株差异极显著。     

一株产紫杉醇中国红豆杉内生真菌的分离和鉴定

从秦巴山区中国红豆杉茎和根中分离得到一批内生真菌,其中一株内生真菌LB-10的发酵液经紫外分光光度法、HPLC和HPLC-MS分析,表明其代谢产物中存在紫杉醇,含量为846.1μg/L。通过形态学研究、ITS序列分析,确定该菌株为绿僵菌。     

茅苍术内生真菌的分离及抗肿瘤细胞活性筛选

近年来,植物内生菌在抗肿瘤天然药物的研究取得了很大的进展。本实验从植物茅苍术中利用纯培养方法和组织块法分离获得57株内生真菌,其中,从根中分离得到20株,叶中分离得到19株,茎中分离得到16株,果实中分离得到2株。对57株内生真菌的抗肿瘤活性进行筛选研究,结果表明,菌株KLMPAL027发酵液对人肝癌HepG2细胞抑制率达到63.76%。     

Modulation of lncRNA H19 enhances resveratrol‐inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress

The phytoalexin resveratrol exhibits anti‐tumour activity in many types of cancer. In this study, we showed that resveratrol suppressed the survival of gastric tumour cells both in vivo and in vitro. Resveratrol promoted apoptosis, autophagy and endoplasmic reticulum (ER) stress in a dose‐dependent manner. RNA‐seq analysis showed that multiple cell death signalling pathways were activated after resveratrol treatment, while the use of ER stress activators (tunicamycin and thapsigargin) in combinatorial with resveratrol led to further inhibition of cancer cell survival. Results also showed that resveratrol altered the expression of several long non‐coding RNAs (lncRNAs), including MEG3, PTTG3P, GAS5, BISPR, MALAT1 and H19. Knockdown of H19 in resveratrol‐treated cells further enhanced the effects of resveratrol on apoptosis, ER stress and cell cycle S‐phase arrest. Furthermore, the migratory ability of resveratrol‐treated cells was dramatically decreased after H19 knockdown. In conclusion, resveratrol inhibited cancer cell survival, while knockdown of lncRNA H19 resulted in increased sensitivity to resveratrol therapy.     

Microbial transformation of polydatin and emodin-8-β-d-glucoside of Polygonum cuspidatum Sieb. et Zucc into resveratrol and emodin respectively by Rhizopus microsporus

Rhizopus microsporus isolated by our laboratory was able to transform polydatin into resveratrol and emodin-8-β-d-glucoside into emodin, respectively, through the fermentation of Polygonum cuspidatum Sieb. et Zucc. The fermentation products were separated and purified by H1020 resin and silica gel column chromatography. Thin layer chromatography (TLC) and high performance liquid chromatography (HPLC) were used to identify the products and evaluate the transformation efficiency. A variety of parameters of submerged state fermentation, including the growth characteristics, the change of β-glucosidase activity and the amount of polydatin, resveratrol, emodin-8-β-d-glucoside, emodin, and the dissolved oxygen, were monitored simultaneously. The amount of resveratrol yielded increased dramatically from 0.04 g/l at the beginning to the maximum value of 0.34 g/l at 36 h of fermentation, and emodin was from 0.4 g/l to 0.65 g/l at 80 h. The transformation rate of glycosides reached 98% and the purity of both resveratrol and emodin was 95%.     

Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation

Recent studies demonstrated that resveratrol, a grape-derived polyphenolic phytoalexin, provides pharmacological preconditioning (PC) of the heart through a NO-dependent mechanism. Because adenosine receptors play a role in PC, we examined whether they play any role in resveratrol PC. Rats were randomly assigned to groups perfused for 15 min with 1) Krebs-Henseleit bicarbonate buffer (KHB) only; 2) KHB containing 10 microM resveratrol; 3) 10 microM resveratrol + 1 microM 8-cyclopentyl-1,3-dimethylxanthine (CPT; adenosine A(1) receptor blocker); 4) 10 microM resveratrol + 1 microM 8-(3-chlorostyryl)caffeine (CSC; adenosine A(2a) receptor blocker); 5) 10 microM resveratrol + 1 microM 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(+/-)-dihydropyridine-3,5-dicarboxylate (MRS-1191; adenosine A(3) receptor blocker); or 6) 10 microM resveratrol + 3 microM 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride [LY-294002, phosphatidylinositol (PI)3-kinase inhibitor], and groups perfused with adenosine receptor blockers alone. Hearts were then subjected to 30-min ischemia followed by 2-h reperfusion. The results demonstrated significant cardioprotection with resveratrol evidenced by improved ventricular recovery and reduced infarct size and cardiomyocyte apoptosis. CPT and MRS 1191, but not CSC, abrogated the cardioprotective abilities of resveratrol, suggesting a role of adenosine A(1) and A(3) receptors in resveratrol PC. Resveratrol induced expression of Bcl-2 and caused its phosphorylation along with phosphorylation of cAMP response element-binding protein (CREB), Akt, and Bad. CPT blocked phosphorylation of Akt and Bad without affecting CREB, whereas MRS 1191 blocked phosphorylation of all compounds, including CREB. LY-294002 partially blocked the cardioprotective abilities of resveratrol. The results indicate that resveratrol preconditions the heart through activation of adenosine A(1) and A(3) receptors, the former transmitting a survival signal through PI3-kinase-Akt-Bcl-2 signaling pathway and the latter protecting the heart through a CREB-dependent Bcl-2 pathway in addition to an Akt-Bcl-2 pathway.     

High yield of endoreduplication induced by ICRF-193: a topoisomerase II catalytic inhibitor

Previous studies have demonstrated that phenolic compounds, including genistein (4',5,7-trihydroxyisoflavone) and resveratrol (3,4',5-trihydroxystilbene), are able to protect against carcinogenesis in animal models. This study was undertaken to examine the ability of genistein and resveratrol to inhibit reactive oxygen species (ROS)-mediated strand breaks in phi X-174 plasmid DNA. H(2)O(2)/Cu(II) and hydroquinone/Cu(II) were used to cause oxidative DNA strand breaks in the plasmid DNA. We demonstrated that the presence of genistein at micromolar concentrations resulted in a marked inhibition of DNA strand breaks induced by either H(2)O(2)/Cu(II) or hydroquinone/Cu(II). Genistein neither affected the Cu(II)/Cu(I) redox cycle nor reacted with H(2)O(2) suggest that genistein may directly scavenge the ROS that participate in the induction of DNA strand breaks. In contrast to the inhibitory effects of genistein, the presence of resveratrol at similar concentrations led to increased DNA strand breaks induced by H(2)O(2)/Cu(II). Further studies showed that in the presence of Cu(II), resveratrol, but not genistein was able to cause DNA strand breaks. Moreover, both Cu(II)/Cu(I) redox cycle and H(2)O(2) were shown to be critically involved in resveratrol/copper-mediated DNA strand breaks. The above results indicate that despite their similar in vivo anticarcinogenic effects, genistein and resveratrol appear to exert different effects on oxidative DNA damage in vitro.     

Resveratrol increases vascular oxidative stress resistance

Epidemiological studies suggest that Mediterranean diets rich in resveratrol are associated with reduced risk of coronary artery disease. However, the mechanisms by which resveratrol exerts its vasculoprotective effects are not completely understood. Because oxidative stress and endothelial cell injury play a critical role in vascular aging and atherogenesis, we evaluated whether resveratrol inhibits oxidative stress-induced endothelial apoptosis. We found that oxidized LDL and TNF-alpha elicited significant increases in caspase-3/7 activity in endothelial cells and cultured rat aortas, which were prevented by resveratrol pretreatment (10(-6)-10(-4) mol/l). The protective effect of resveratrol was attenuated by inhibition of glutathione peroxidase and heme oxygenase-1, suggesting a role for antioxidant systems in the antiapoptotic action of resveratrol. Indeed, resveratrol treatment protected cultured aortic segments and/or endothelial cells against increases in intracellular H(2)O(2) levels and H(2)O(2)-mediated apoptotic cell death induced by oxidative stressors (exogenous H(2)O(2), paraquat, and UV light). Resveratrol treatment also attenuated UV-induced DNA damage (comet assay). Resveratrol treatment upregulated the expression of glutathione peroxidase, catalase, and heme oxygenase-1 in cultured arteries, whereas it had no significant effect on the expression of SOD isoforms. Resveratrol also effectively scavenged H(2)O(2) in vitro. Thus resveratrol seems to increase vascular oxidative stress resistance by scavenging H(2)O(2) and preventing oxidative stress-induced endothelial cell death. We propose that the antioxidant and antiapoptotic effects of resveratrol, together with its previously described anti-inflammatory actions, are responsible, at least in part, for its cardioprotective effects.     

Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells

Resveratrol is a promising chemopreventive agent that mediates many cellular targets involved in cancer signaling pathways. p53 has been suggested to play a role in the anticancer properties of resveratrol. We investigated resveratrol-induced cytotoxicity in H1299 cells, which are non-small lung cancer cells that have a partial deletion of the gene that encodes the p53 protein. The results for H1299 cells were compared with those for three cell lines that constitutively express wild-type p53: breast cancer MCF-7, adenocarcinomic alveolar basal epithelia A549 and non-small lung cancer H460. Cell viability assays revealed that resveratrol reduced the viability of all four of these cell lines in a dose- and time-dependent manner. MCF-7, A549 and H460 cells were more sensitive to resveratrol than were H1299 cells when exposed to the drug for 24 h at concentrations above 100 µM. Resveratrol also increased the p53 protein levels in MCF-7 cells without altering the p53 mRNA levels, suggesting a post-translational modulation of the protein. The resveratrol-induced cytotoxicity in these cells was partially mediated by p53 and involved the activation of caspases 9 and 7 and the cleavage of PARP. In H1299 cells, resveratrol-induced cytotoxicity was less pronounced and (in contrast to MCF-7 cells) cell death was not accompanied by caspase activation. These findings are consistent with the observation that MCF-7 cells were positively labeled by TUNEL following exposure to 100 µM resveratrol whereas H1299 cells under similar conditions were not labeled by TUNEL. The transient transfection of a wild-type p53-GFP gene caused H1299 cells to become more responsive to the pro-apoptotic properties of resveratrol, similarly to findings in the p53-positive MCF-7 cells. Our results suggest a possible therapeutic strategy based on the use of resveratrol for the treatment of tumors that are typically unresponsive to conventional therapies because of the loss of normal p53 function.     

Resveratrol protects H9c2 embryonic rat heart derived cells from oxidative stress by inducing autophagy: role of p38 mitogen-activated protein kinase

Recently, many studies have attempted to illustrate the mechanism of autophagy in protection against oxidative stress to the heart induced by H(2)O(2). However, whether resveratrol-induced autophagy involves the p38 mitogen-activated protein kinase (MAPK) pathway is still unknown. This study aimed to investigate whether treating H9c2 cells with resveratrol increases autophagy and attenuates the cell death and apoptosis induced by oxidative stress via the p38 MAPK pathway. Resveratrol with or without SB202190, an inhibitor of the p38 MAPK pathway, was added 30 min before H(2)O(2). After H(2)O(2) treatment, the cells were incubated under 5% CO(2) at 37 °C for 24 h to assess cell survival and death or incubated for 20 min for Western blot and transmission electron microscopy. Flow cytometry was used to detect apoptosis after 6 h of H(2)O(2) treatment. Resveratrol at 20 μmol/L protected H9c2 cells treated with 100 μmol/L H(2)O(2) from oxidative damage. It increased cell survival and markedly decrease lactate dehydrogenase release. In addition, resveratrol increased autophagy and decreased H(2)O(2)-induced apoptosis. Furthermore, the protective effects of resveratrol were inhibited by 10 μmol/L SB202190. Thus, resveratrol protected H(2)O(2)-treated H9c2 cells by upregulating autophagy via the p38 MAPK pathway.     

Resveratrol Induces Long-Lasting IL-8 Expression and Peculiar EGFR Activation/Distribution in Human Keratinocytes: Mechanisms and Implications for Skin Administration

Anti-inflammatory and skin tumour preventing effects of resveratrol have been extensively studied pre-clinically and resveratrol has been proposed for clinical investigations. To provide a basis or/and limitations for topical administration to human skin, molecular mechanisms underlying resveratrol effects towards normal human epidermal keratinocytes (NHEK) were evaluated. NHEK were challenged by either resveratrol alone or by its combination with TNFalpha or TGFalpha, and time-dependent molecular events were monitored. Interleukin 8 (IL-8) expression and its mRNA stability, ERK1/2, p65/RelA, and EGFR phosphorylation were determined. Intracellular distribution of EGFR/P-EGFR was measured in the membrane, cytoplasmic, and nuclear fractions. Specific DNA binding activity of NFκB (p65/RelA) and AP-1(c-Fos), NHEK proliferation, and molecular markers of apoptosis/cell cycle were detected. Resveratrol induced delayed, long-lasting and steadily growing IL-8 gene and protein over-expression as well as enhanced EGFR phosphorylation, both abrogated by the EGFR kinase inhibitor PD168393. However, resveratrol did not act as a phosphatase inhibitor. ERK phosphorylation was transiently inhibited at early time-points and activated at 6–24 h. Accordingly, c-Fos-specific DNA binding was increased by resveratrol. Cellular distribution of EGFR/P-EGFR was shifted to membrane and nucleus while cytosolic levels were reduced concomitant with enhanced degradation. Notwithstanding high nuclear levels of EGFR/P-EGFR, spontaneous and TGFalpha-triggered cell proliferation was strongly suppressed by resveratrol mainly through cell cycle arrest.

Conclusions/Significance

Resveratrol synergized with TNFα in the induction of delayed, long-lasting IL-8 expression through sustained EGFR-ERK axis activation. The time course indicates that resveratrol metabolites could be implicated. Topical administration of Resv to psoriatic patients over-expressing TNFα, IL-8 and EGFR-ERK in the skin should be cautiously considered. Since high nuclear levels of EGFR correspond to increased risk of tumorigenesis, chronic resveratrol application to the skin may be potentially dangerous. Wound healing acceleration by resveratrol could not be envisaged due to its anti-proliferative effects towards normal keratinocytes.     

白藜芦醇抑制大鼠下丘脑脑片室旁核神经元放电

本文旨在研究白藜芦醇(resveratrol)对下丘脑脑片室旁核神经元放电的影响.应用玻璃微电极细胞外记录单位放电技术,在下丘脑脑片上观察白藜芦醇对静息状态下室旁核神经元放电的影响.结果如下:(1)在29张下丘脑脑片室旁核神经元放电单位给予白藜芦醇(O.05,0.5,5.0 μmol/L)2 min,有28张脑片(96.6%)放电频率显著降低,且呈剂量依赖性;(2)预先用0.2mmol/L的L.glutamate灌流8张下丘脑脑片,8张脑片(100%)放电频率显著增加,表现为癫痫样放电,该放电可被白藜芦醇(5.0 μmol/L)灌流2 min抑制:(3)预先用L型钙通道开放剂Bay K8644(0.1μmol/L)灌流8张下丘脑脑片,8张脑片(100%)放电频率显著增加,该放电可被白藜芦醇(5.0 μmol/L)灌流2 min抑制;(4)用一氧化氮合酶抑制剂Nω-nitro.L-arginine methyl ester(L-NAME)50μmol/L灌流8张下丘脑脑片,7张脑片(87.5%)放电频率显著增加,该放电可被白藜芦醇(5.0 μmol/L)灌流2 min抑制.以上结果提示,白藜芦醇抑制下丘脑室旁核神经元自发放电,可能通过降低心血管中枢的活动性而产生中枢保护作用.这种抑制作用可能与白藜芦醇抑制L型钙通道、减少钙内流有关,与NO释放无关.     

Effect of resveratrol on proliferation and differentiation of embryonic cardiomyoblasts

Resveratrol (trans-3,5,4′-trihydroxystilbene), a polyphenolic compound found largely in the skins of red grapes, has been used as a nutritional supplement or an investigational new drug for prevention of cardiovascular diseases. Previous reports showed that resveratrol had a protective effect against oxidative agent-induced cell injury. Our studies indicate that resveratrol plays a role in the differentiation of cardiomyoblasts. The cardiomyoblast cell line, H9c2, was exposed to 30-120 μM resveratrol for up to 5 days. Resveratrol inhibits cardiomyoblast proliferation without causing cells injury. Moreover, resveratrol treatment modulated the differentiation of morphological characteristics including elongation and cell fusion in cardiomyoblasts. Proliferation and differentiation of H9c2 cells were further revealed by measurement of the mRNA expression of a cell cycle marker (CDK2), a differentiation marker (myogenin), and a contractile apparatus protein (MLC-2). Gene expression analysis revealed that resveratrol promoted entry into cell cycle arrest but extended the myogenic differentiation progress. These results have implications for the role of resveratrol in modulating cell cycle control and differentiation in cardiomyoblasts.